DC Circ. Upholds FDA's Abuse-Deterrent Opioid Denial
The D.C. Circuit on Friday upheld the U.S. Food and Drug Administration's denial of Pharmaceutical Manufacturing Research Services Inc.'s application for an abuse-deterrent form of oxycodone because there was no evidence...To view the full article, register now.
Already a subscriber? Click here to view full article